Results 251 to 260 of about 61,872 (307)

The Influence of Lifestyle Factors on the Occurrence of Wild-Type Transthyretin Cardiac Amyloidosis

Yuichi Baba, Masahiko Sakaguchi, Yuri Ochi, Toru Kubo, Kei Kawada, Takayoshi Hirota, Naohito Yamasaki, Hiroaki Kitaoka   +7 more
openalex   +2 more sources

The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis. [PDF]

Sci Rep
Holcman K, Rubiś P, Ćmiel B, Ząbek A, Boczar K, Stępień-Wroniecka A, Graczyk K, Mróz K, Dziewięcka E, Mateusz W, Szczepara S, Kurek M, Gutkowska K, Podolec P, Kostkiewicz M.   +14 more
europepmc   +1 more source

Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis

Helena F Pernice, Adrian L. Knorz, Paul J Wetzel, Carolin Herrmann, Harisa Muratovic, Finn Rieber, Eleonora Asaad, G. Fiss, Gina Barzen, Elisabeth Blüthner, Fabian Knebel, Sebastian Spethmann, Daniel Messroghli, Bettina Heidecker, Anna Brand, Christoph Wetz, Carsten Tschöpe, Katrin Hahn   +17 more
openalex   +1 more source

Understanding Race, Genotype, and Socioeconomic Status in Transthyretin Amyloid Cardiomyopathy

Trejeeve Martyn, Julia Simkowski, Mazen Hanna   +2 more
openalex   +1 more source

Multisystemic manifestations of a rare Glu89Lys (p. Glu109Lys) transthyretin amyloidosis: a case report of an East Asian female. [PDF]

BMC Neurol
Huang L, Zhou H, Chen J, Fang T, Lin Q.
europepmc   +1 more source

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy: When the Heart Isn't the Only Matter. [PDF]

JACC Adv
Zeis T, Chen V, Tang WHW, Goyal P, Hanna M, Damluji A, Martyn T.   +6 more
europepmc   +1 more source

Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis

, 2005
Nora S. Green, Ted R. Foss, Jeffery W. Kelly   +2 more
openalex   +1 more source

The evolving landscape of restrictive cardiomyopathy treatment: clinical trial trends and future directions. [PDF]

Front Cardiovasc Med
Deng B, Liu W.
europepmc   +1 more source

Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis. [PDF]

JACC Adv
Terentes-Printzios D, Koilakou ME, Alexiou P, Antonopoulos A, Kasiakogias A, Katsimichas T, Lazaros G, Tsampras T, Kourti FE, Ioakeimidis N, Tsioufis K, Vlachopoulos C.   +11 more
europepmc   +1 more source

Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.

JAMA Cardiol
Alexander KM, Davis MK, Akinboboye O, Berk J, Bhatt K, Cappelli F, Cuddy SAM, Fontana M, Garcia-Pavia P, Gillmore JD, Griffin JM, Grodin JL, Judge DP, Khouri MG, Lam K, Masri A, Maurer MS, Obici L, Ruberg FL, Sarswat N, Shah K, Soman P, Stern L, Wright R, Xiong K, Cao X, Lystig T, Tamby JF, Castaño A, Katz L, Sinha U, Fox JC, Solomon SD, Grogan M.   +33 more
europepmc   +1 more source